A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management infrastructure which includes storage and dispensing automation powered by an intelligence ecosystem.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.2B | 1.1B | 1.1B | 1.3B | 1.1B |
| Net Income | 2.1M | 2.1M | 13M | -20M | 5.6M | 78M |
| EPS | $0.04 | $0.04 | $0.27 | $-0.45 | $0.12 | $1.62 |
| Free Cash Flow | 87M | 87M | 151M | 140M | 30M | 203M |
| ROIC | 0.1% | 0.3% | - | -1.4% | 0.4% | 8.9% |
| Gross Margin | 42.5% | 42.5% | 42.3% | 43.3% | 45.4% | 49.0% |
| Debt/Equity | 0.17 | 0.17 | 0.31 | 0.52 | 0.55 | 0.47 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 5.2M | 5.2M | - | -35M | -2.3M | 90M |
| Operating Margin | 0.4% | 0.4% | - | -3.0% | -0.2% | 7.9% |
| ROE | 0.2% | 0.2% | 1.0% | -1.8% | 0.5% | 7.4% |
| Shares Outstanding | 51M | 51M | 46M | 45M | 47M | 48M |
OMNICELL, INC. passes 3 of 9 quality checks, indicating weak fundamentals.
OMNICELL, INC. trades at 875.2x trailing earnings, compared to its 15-year median P/E of 62.8x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 18.3x vs a median of 30.6x. The company's 5-year average ROIC is 2.0% with a gross margin of 44.5%. Total shareholder yield (buybacks) is 4.3%. At current prices, the estimated annualized return to fair value is +2.3%.
OMNICELL, INC. (OMCL) has a current P/E ratio of 875.2, compared to its historical median P/E of 62.8. The stock is currently considered Expensive based on its historical valuation range.
OMNICELL, INC. (OMCL) has a 5-year average return on invested capital (ROIC) of 2.0%. This is below average and may indicate limited pricing power.
OMNICELL, INC. (OMCL) has a market capitalization of $1.8B. It is classified as a small-cap stock.
OMNICELL, INC. (OMCL) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 4.32%.
Based on historical P/E analysis, OMNICELL, INC. (OMCL) appears expensive. The current P/E of 875.2 is 1294% above its historical median of 62.8. The estimated fair value CAGR (P/E method) is -28.1%.
OMNICELL, INC. (OMCL) operates in the Electronic Computers industry, within the Technology sector.
OMNICELL, INC. (OMCL) reported annual revenue of $1.2 billion in its most recent fiscal year, based on SEC EDGAR filings.
OMNICELL, INC. (OMCL) has a net profit margin of 0.2%. This is a modest margin.
OMNICELL, INC. (OMCL) generated $87 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
OMNICELL, INC. (OMCL) has a debt-to-equity ratio of 0.17. This indicates a conservatively financed balance sheet.
OMNICELL, INC. (OMCL) reported earnings per share (EPS) of $0.04 in its most recent fiscal year.
OMNICELL, INC. (OMCL) has a return on equity (ROE) of 0.2%. This indicates moderate shareholder returns.
OMNICELL, INC. (OMCL) has a 5-year average gross margin of 44.5%. This indicates decent pricing power.
The Ledger Terminal provides 16 years of financial data for OMNICELL, INC. (OMCL), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
OMNICELL, INC. (OMCL) has a book value per share of $24.01, based on its most recent annual SEC filing.